{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:43:55Z","timestamp":1780058635702,"version":"3.54.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant funded by the Korean government","award":["RS-2023-00211504"],"award-info":[{"award-number":["RS-2023-00211504"]}]},{"name":"Basic Science Research Program to the Research Institute for Basic Sciences (RIBS) of Jeju National University through the NRF, funded by the Ministry of Education","award":["2019R1A6A1A10072987"],"award-info":[{"award-number":["2019R1A6A1A10072987"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76736-9","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T11:02:15Z","timestamp":1729854135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adjuvant potential of Peyssonnelia caulifera extract on the efficacy of an influenza vaccine in a murine model"],"prefix":"10.1038","volume":"14","author":[{"given":"Thi Len","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Yeon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ju","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"76736_CR1","doi-asserted-by":"crossref","unstructured":"Wang, B. & Loeb, M. in Vaccinations 89\u2013103 (Elsevier 2019).","DOI":"10.1016\/B978-0-323-55435-0.00006-9"},{"key":"76736_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano, A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 391, 1285\u20131300 (2018).","journal-title":"Lancet"},{"key":"76736_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-019-2539-x","volume":"23","author":"AC Kalil","year":"2019","unstructured":"Kalil, A. C. & Thomas, P. G. Influenza virus-related critical illness: pathophysiology and epidemiology. Crit. Care. 23, 1\u20137 (2019).","journal-title":"Crit. Care"},{"key":"76736_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/00333549101250S305","volume":"125","author":"JK Taubenberger","year":"2010","unstructured":"Taubenberger, J. K. & Morens, D. M. Influenza: the once and future pandemic. Public Health Rep. 125, 15\u201326 (2010).","journal-title":"Public Health Rep."},{"key":"76736_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/vim.2017.0141","volume":"31","author":"H Kim","year":"2018","unstructured":"Kim, H., Webster, R. G. & Webby, R. J. Influenza virus: dealing with a drifting and shifting pathogen. Viral Immunol. 31, 174\u2013183 (2018).","journal-title":"Viral Immunol."},{"key":"76736_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/COH.0b013e32833d2cdb","volume":"5","author":"D Carter","year":"2010","unstructured":"Carter, D. & Reed, S. G. Role of adjuvants in modeling the immune response. Curr. Opin. HIV AIDS. 5, 409 (2010).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"76736_CR7","doi-asserted-by":"publisher","first-page":"175632","DOI":"10.1016\/j.ejphar.2023.175632","volume":"945","author":"C Reyes","year":"2023","unstructured":"Reyes, C. & Patarroyo, M. A. Adjuvants approved for human use: what do we know and what do we need to know for designing good adjuvants? Eur. J. Pharmacol. 945, 175632 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"76736_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao, T. et al. Vaccine adjuvants: mechanisms and platforms. Signal. Transduct. Target. Therapy. 8, 283 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"76736_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/21645515.2017.1415684","volume":"14","author":"JS Tregoning","year":"2018","unstructured":"Tregoning, J. S., Russell, R. F. & Kinnear, E. Adjuvanted influenza vaccines. Hum. Vaccines Immunotherapeutics. 14, 550\u2013564. https:\/\/doi.org\/10.1080\/21645515.2017.1415684 (2018).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"76736_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2013.12.007","volume":"28","author":"E Oleszycka","year":"2014","unstructured":"Oleszycka, E. & Lavelle, E. C. Immunomodulatory properties of the vaccine adjuvant alum. Curr. Opin. Immunol. 28, 1\u20135 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"76736_CR11","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","volume":"183","author":"AM Didierlaurent","year":"2009","unstructured":"Didierlaurent, A. M. et al. AS04, an aluminum salt-and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J. Immunol. 183, 6186\u20136197 (2009).","journal-title":"J. Immunol."},{"key":"76736_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/clinids\/2.3.370","volume":"2","author":"R Edelman","year":"1980","unstructured":"Edelman, R. Vaccine adjuvants. Rev. Infect. Dis. 2, 370\u2013383 (1980).","journal-title":"Rev. Infect. Dis."},{"key":"76736_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/vaccines3020320","volume":"3","author":"A Di Pasquale","year":"2015","unstructured":"Di Pasquale, A., Preiss, S., Tavares Da Silva, F. & Gar\u00e7on, N. Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines. 3, 320\u2013343 (2015).","journal-title":"Vaccines"},{"key":"76736_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMra1204186","volume":"368","author":"GJ Nabel","year":"2013","unstructured":"Nabel, G. J. Designing tomorrow\u2019s vaccines. N. Engl. J. Med. 368, 551\u2013560 (2013).","journal-title":"N. Engl. J. Med."},{"key":"76736_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","volume":"33","author":"RL Coffman","year":"2010","unstructured":"Coffman, R. L., Sher, A. & Seder, R. A. Vaccine adjuvants: putting innate immunity to work. Immunity. 33, 492\u2013503 (2010).","journal-title":"Immunity"},{"key":"76736_CR16","unstructured":"Dubensky, T. W. Jr & Reed, S. G. in Seminars in immunology. 155\u2013161 (Elsevier)."},{"key":"76736_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1529-8817.2012.01222.x","volume":"48","author":"MD Guiry","year":"2012","unstructured":"Guiry, M. D. How many species of algae are there? J. Phycol. 48, 1057\u20131063 (2012).","journal-title":"J. Phycol."},{"key":"76736_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/ps.2780390208","volume":"39","author":"RJ Cannell","year":"1993","unstructured":"Cannell, R. J. Algae as a source of biologically active products. Pest. Sci. 39, 147\u2013153 (1993).","journal-title":"Pest. Sci."},{"key":"76736_CR19","first-page":"243","volume":"6","author":"A Manilal","year":"2010","unstructured":"Manilal, A. et al. Antifouling potentials of seaweeds collected from the southwest coast of India. World J. Agricultural Sci. 6, 243\u2013248 (2010).","journal-title":"World J. Agricultural Sci."},{"key":"76736_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/md18070347","volume":"18","author":"MA Hannan","year":"2020","unstructured":"Hannan, M. A. et al. Neuroprotective potentials of marine algae and their bioactive metabolites: pharmacological insights and therapeutic advances. Mar. Drugs. 18, 347 (2020).","journal-title":"Mar. Drugs"},{"key":"76736_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/md17030175","volume":"17","author":"PA Hwang","year":"2019","unstructured":"Hwang, P. A., Lin, H. T. V., Lin, H. Y. & Lo, S. K. Dietary supplementation with low-molecular-weight fucoidan enhances innate and adaptive immune responses and protects against Mycoplasma pneumoniae antigen stimulation. Mar. Drugs. 17, 175 (2019).","journal-title":"Mar. Drugs"},{"key":"76736_CR22","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1016\/j.vaccine.2018.07.038","volume":"36","author":"Y Jin","year":"2018","unstructured":"Jin, Y., Li, P. & Wang, F. \u03b2-glucans as potential immunoadjuvants: a review on the adjuvanticity, structure-activity relationship and receptor recognition properties. Vaccine. 36, 5235\u20135244 (2018).","journal-title":"Vaccine"},{"key":"76736_CR23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4103\/0250-474X.119829","volume":"75","author":"F Sarei","year":"2013","unstructured":"Sarei, F., Dounighi, N. M., Zolfagharian, H., Khaki, P. & Bidhendi, S. M. Alginate nanoparticles as a promising adjuvant and vaccine delivery system. Indian J. Pharm. Sci. 75, 442 (2013).","journal-title":"Indian J. Pharm. Sci."},{"key":"76736_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1263\/jbb.101.87","volume":"101","author":"P Spolaore","year":"2006","unstructured":"Spolaore, P., Joannis-Cassan, C., Duran, E. & Isambert, A. Commercial applications of microalgae. J. Biosci. Bioeng. 101, 87\u201396 (2006).","journal-title":"J. Biosci. Bioeng."},{"key":"76736_CR25","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1002\/fsn3.3605","volume":"11","author":"TL Ho","year":"2023","unstructured":"Ho, T. L. et al. Immunostimulatory effects of marine algae extracts on in vitro antigen-presenting cell activation and in vivo immune cell recruitment. Food Sci. Nutr. 11, 6560 (2023).","journal-title":"Food Sci. Nutr."},{"key":"76736_CR26","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.ajpath.2013.06.023","volume":"183","author":"R Gao","year":"2013","unstructured":"Gao, R. et al. Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis. Am. J. Pathol. 183, 1258\u20131268 (2013).","journal-title":"Am. J. Pathol."},{"key":"76736_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10096-010-1041-9","volume":"30","author":"T Takano","year":"2011","unstructured":"Takano, T., Tajiri, H., Kashiwagi, Y., Kimura, S. & Kawashima, H. Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection. Eur. J. Clin. Microbiol. Infect. Dis. 30, 117\u2013120 (2011).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"76736_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cmi.2015.74","volume":"13","author":"Q Liu","year":"2016","unstructured":"Liu, Q., Zhou, Y. & Yang, Z. -q. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol. Immunol. 13, 3\u201310 (2016).","journal-title":"Cell Mol. Immunol."},{"key":"76736_CR29","doi-asserted-by":"publisher","first-page":"108652","DOI":"10.1016\/j.clim.2020.108652","volume":"223","author":"VA Ryabkova","year":"2021","unstructured":"Ryabkova, V. A., Churilov, L. P. & Shoenfeld, Y. Influenza infection, SARS, MERS and COVID-19: cytokine storm\u2013the common denominator and the lessons to be learned. Clin. Immunol. 223, 108652 (2021).","journal-title":"Clin. Immunol."},{"key":"76736_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fimmu.2018.00320","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen, X. et al. Host immune response to influenza a virus infection. Front. Immunol. 9, 320 (2018).","journal-title":"Front. Immunol."},{"key":"76736_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1158\/2326-6066.CIR-13-0102","volume":"1","author":"I Mellman","year":"2013","unstructured":"Mellman, I. Dendritic cells: master regulators of the immune response. Cancer Immunol. Res. 1, 145\u2013149 (2013).","journal-title":"Cancer Immunol. Res."},{"key":"76736_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-immunol-101320-031555","volume":"40","author":"KM Sheu","year":"2022","unstructured":"Sheu, K. M. & Hoffmann, A. Functional hallmarks of healthy macrophage responses: their regulatory basis and disease relevance. Annu. Rev. Immunol. 40, 295\u2013321 (2022).","journal-title":"Annu. Rev. Immunol."},{"key":"76736_CR33","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1038\/s41598-017-01868-0","volume":"7","author":"W Fang","year":"2017","unstructured":"Fang, W. et al. Identification and activation of TLR4-mediated signalling pathways by alginate-derived guluronate oligosaccharide in RAW264. 7 macrophages. Sci. Rep. 7, 1663 (2017).","journal-title":"Sci. Rep."},{"key":"76736_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.algal.2017.10.008","volume":"28","author":"M Berri","year":"2017","unstructured":"Berri, M. et al. Ulvan from Ulva armoricana (Chlorophyta) activates the PI3K\/Akt signalling pathway via TLR4 to induce intestinal cytokine production. Algal Res. 28, 39\u201347 (2017).","journal-title":"Algal Res."},{"key":"76736_CR35","doi-asserted-by":"publisher","first-page":"44822","DOI":"10.1038\/srep44822","volume":"7","author":"L Zhou","year":"2017","unstructured":"Zhou, L. et al. Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo. Sci. Rep. 7, 44822. https:\/\/doi.org\/10.1038\/srep44822 (2017).","journal-title":"Sci. Rep."},{"key":"76736_CR36","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.vaccine.2015.02.063","volume":"33","author":"J Li","year":"2015","unstructured":"Li, J. et al. Pleurotus ferulae water extract enhances the maturation and function of murine bone marrow-derived dendritic cells through TLR4 signaling pathway. Vaccine. 33, 1923\u20131933 (2015).","journal-title":"Vaccine"},{"key":"76736_CR37","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1098\/rspb.2001.1644","volume":"268","author":"R Viola","year":"2001","unstructured":"Viola, R., Nyvall, P. & Peders\u00e9n, M. The unique features of starch metabolism in red algae. Proc. R. Soc. Lond. B Biol. Sci. 268, 1417\u20131422 (2001).","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"76736_CR38","unstructured":"Fritsch, F. E. The Structure and Reproduction of the Algae Vol 2 Foreword, Phaeophyceae, Rhodophyceae, Myxophyceae (Cambridge University Press, 1945)."},{"key":"76736_CR39","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","volume":"18","author":"J Liu","year":"2021","unstructured":"Liu, J., Zhang, X., Cheng, Y. & Cao, X. Dendritic cell migration in inflammation and immunity. Cell Mol. Immunol. 18, 2461\u20132471. https:\/\/doi.org\/10.1038\/s41423-021-00726-4 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"76736_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2019.12.012","volume":"472","author":"Y Jeong","year":"2020","unstructured":"Jeong, Y. et al. Dendritic cell activation by an E. coli-derived monophosphoryl lipid a enhances the efficacy of PD-1 blockade. Cancer Lett. 472, 19\u201328 (2020).","journal-title":"Cancer Lett."},{"key":"76736_CR41","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/intimm\/12.6.807","volume":"12","author":"G De Becker","year":"2000","unstructured":"De Becker, G. et al. The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells. Int. Immunol. 12, 807\u2013815 (2000).","journal-title":"Int. Immunol."},{"key":"76736_CR42","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","volume":"357","author":"IJ Amanna","year":"2007","unstructured":"Amanna, I. J., Carlson, N. E. & Slifka, M. K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357, 1903\u20131915 (2007).","journal-title":"N. Engl. J. Med."},{"key":"76736_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nri2510","volume":"9","author":"P Marrack","year":"2009","unstructured":"Marrack, P., McKee, A. S. & Munks, M. W. Towards an understanding of the adjuvant action of aluminium. Nat. Rev. Immunol. 9, 287\u2013293 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"76736_CR44","doi-asserted-by":"publisher","first-page":"e13776","DOI":"10.1371\/journal.pone.0013776","volume":"5","author":"X Chen","year":"2010","unstructured":"Chen, X. et al. A novel laser vaccine adjuvant increases the motility of antigen presenting cells. PLoS One. 5, e13776 (2010).","journal-title":"PLoS One"},{"key":"76736_CR45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1586\/14760584.2.2.269","volume":"2","author":"DT O\u2019Hagan","year":"2003","unstructured":"O\u2019Hagan, D. T. & Singh, M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev. Vaccines. 2, 269\u2013283 (2003).","journal-title":"Expert Rev. Vaccines"},{"key":"76736_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","volume":"32","author":"RK Gupta","year":"1998","unstructured":"Gupta, R. K. Aluminum compounds as vaccine adjuvants. Adv. Drug Deliv. Rev. 32, 155\u2013172 (1998).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"76736_CR47","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/irv.12664","volume":"13","author":"E Gianchecchi","year":"2019","unstructured":"Gianchecchi, E. et al. How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions. Influenza Other Respir. Viruses. 13, 429\u2013437 (2019).","journal-title":"Influenza Other Respir. Viruses"},{"key":"76736_CR48","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","volume":"3","author":"JK Taubenberger","year":"2008","unstructured":"Taubenberger, J. K. & Morens, D. M. The pathology of influenza virus infections. Annu. Rev. Pathol. Mech. Dis. 3, 499\u2013522 (2008).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"76736_CR49","doi-asserted-by":"crossref","unstructured":"Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A. & Klenk, H. D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proceedings of the National Academy of Sciences 101, 4620\u20134624 (2004).","DOI":"10.1073\/pnas.0308001101"},{"key":"76736_CR50","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.immuni.2013.10.010","volume":"39","author":"V Bronte","year":"2013","unstructured":"Bronte, V. & Pittet, M. J. The spleen in local and systemic regulation of immunity. Immunity. 39, 806\u2013818 (2013).","journal-title":"Immunity"},{"key":"76736_CR51","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nri1669","volume":"5","author":"RE Mebius","year":"2005","unstructured":"Mebius, R. E. & Kraal, G. Structure and function of the spleen. Nat. Rev. Immunol. 5, 606\u2013616 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"76736_CR52","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/S0264-410X(02)00169-X","volume":"20","author":"H HogenEsch","year":"2002","unstructured":"HogenEsch, H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine. 20, S34\u2013S39 (2002).","journal-title":"Vaccine"},{"key":"76736_CR53","doi-asserted-by":"publisher","first-page":"e0139916","DOI":"10.1371\/journal.pone.0139916","volume":"10","author":"KH Kim","year":"2015","unstructured":"Kim, K. H. et al. Alum adjuvant enhances protection against respiratory syncytial virus but exacerbates pulmonary inflammation by modulating multiple innate and adaptive immune cells. PloS One. 10, e0139916 (2015).","journal-title":"PloS One"},{"key":"76736_CR54","doi-asserted-by":"publisher","first-page":"1217181","DOI":"10.3389\/fimmu.2023.1217181","volume":"14","author":"LA Chang","year":"2023","unstructured":"Chang, L. A. et al. Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia. Front. Immunol. 14, 1217181 (2023).","journal-title":"Front. Immunol."},{"key":"76736_CR55","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell. 124, 783\u2013801 (2006).","journal-title":"Cell"},{"key":"76736_CR56","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s12276-021-00602-1","volume":"53","author":"Y Kasuga","year":"2021","unstructured":"Kasuga, Y., Zhu, B., Jang, K. J. & Yoo, J. S. Innate immune sensing of coronavirus and viral evasion strategies. Exp. Mol. Med. 53, 723\u2013736 (2021).","journal-title":"Exp. Mol. Med."},{"key":"76736_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway Jr","year":"2002","unstructured":"Janeway, C. A. Jr & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197\u2013216 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"76736_CR58","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bbrc.2009.08.062","volume":"388","author":"H Kumar","year":"2009","unstructured":"Kumar, H., Kawai, T. & Akira, S. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388, 621\u2013625 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"76736_CR59","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","volume":"6","author":"D Li","year":"2021","unstructured":"Li, D. & Wu, M. Pattern recognition receptors in health and diseases. Signal. Transduct. Target. Therapy. 6, 291 (2021).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"76736_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","volume":"239","author":"MS Duthie","year":"2011","unstructured":"Duthie, M. S., Windish, H. P., Fox, C. B. & Reed, S. G. Use of defined TLR ligands as adjuvants within human vaccines. Immunol. Rev. 239, 178\u2013196 (2011).","journal-title":"Immunol. Rev."},{"key":"76736_CR61","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675\u2013680 (2001).","journal-title":"Nat. Immunol."},{"key":"76736_CR62","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki, T. & Kawai, T. Toll-like receptor signaling pathways. Front. Immunol. 5, 461 (2014).","journal-title":"Front. Immunol."},{"key":"76736_CR63","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/ni1112","volume":"5","author":"A Iwasaki","year":"2004","unstructured":"Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987\u2013995 (2004).","journal-title":"Nat. Immunol."},{"key":"76736_CR64","doi-asserted-by":"crossref","unstructured":"Jin, B., Sun, T., Yu, X. H., Yang, Y. X. & Yeo, A. E. The effects of TLR activation on T-cell development and differentiation. Clinical and Developmental Immunology (2012).\u00a0","DOI":"10.1155\/2012\/836485"},{"key":"76736_CR65","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature06939","volume":"453","author":"SC Eisenbarth","year":"2008","unstructured":"Eisenbarth, S. C., Colegio, O. R., O\u2019Connor, W., Sutterwala, F. S. & Flavell, R. A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 453, 1122\u20131126 (2008).","journal-title":"Nature"},{"key":"76736_CR66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nri3694","volume":"14","author":"E De Gregorio","year":"2014","unstructured":"De Gregorio, E. & Rappuoli, R. From empiricism to rational design: a personal perspective of the evolution of vaccine development. Nat. Rev. Immunol. 14, 505\u2013514 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"76736_CR67","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","volume":"20","author":"B Pulendran","year":"2021","unstructured":"Pulendran, B., Arunachalam, S., O\u2019Hagan, D. T. & P. & Emerging concepts in the science of vaccine adjuvants. Nat. Rev. Drug Discovery. 20, 454\u2013475. https:\/\/doi.org\/10.1038\/s41573-021-00163-y (2021).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"76736_CR68","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","volume":"82","author":"N Petrovsky","year":"2004","unstructured":"Petrovsky, N. & Aguilar, J. C. Vaccine adjuvants: current state and future trends. Immunol. Cell Biol. 82, 488\u2013496 (2004).","journal-title":"Immunol. Cell Biol."},{"key":"76736_CR69","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1016\/j.vaccine.2007.01.111","volume":"25","author":"J Aguilar","year":"2007","unstructured":"Aguilar, J. & Rodriguez, E. Vaccine adjuvants revisited. Vaccine. 25, 3752\u20133762 (2007).","journal-title":"Vaccine"},{"key":"76736_CR70","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1080\/21645515.2019.1625644","volume":"15","author":"TF Schwarz","year":"2019","unstructured":"Schwarz, T. F. et al. A ten-year study of immunogenicity and safety of the AS04-HPV-16\/18 vaccine in adolescent girls aged 10\u201314 years. Hum. Vaccines Immunotherapeutics. 15, 1970\u20131979 (2019).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"76736_CR71","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.1016\/j.vaccine.2010.06.065","volume":"28","author":"A Carmona","year":"2010","unstructured":"Carmona, A. et al. Immunogenicity and safety of AS03-adjuvanted 2009 influenza a H1N1 vaccine in children 6\u201335 months. Vaccine. 28, 5837\u20135844 (2010).","journal-title":"Vaccine"},{"key":"76736_CR72","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jnci\/93.4.284","volume":"93","author":"CD Harro","year":"2001","unstructured":"Harro, C. D. et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J. Natl Cancer Inst. 93, 284\u2013292 (2001).","journal-title":"J. Natl Cancer Inst."},{"key":"76736_CR73","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/adhm.201200181","volume":"2","author":"L Huntimer","year":"2013","unstructured":"Huntimer, L. et al. Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle\u2010based platform for vaccine delivery. Adv. Healthc. Mater. 2, 369\u2013378 (2013).","journal-title":"Adv. Healthc. Mater."},{"key":"76736_CR74","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s11095-013-1224-z","volume":"31","author":"W Zhang","year":"2014","unstructured":"Zhang, W. et al. Comparison of PLA microparticles and alum as adjuvants for H5N1 influenza split vaccine: adjuvanticity evaluation and preliminary action mode analysis. Pharm. Res. 31, 1015\u20131031 (2014).","journal-title":"Pharm. Res."},{"key":"76736_CR75","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"76736_CR76","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12931-023-02448-9","volume":"24","author":"SY Ahn","year":"2023","unstructured":"Ahn, S. Y. et al. Chronic allergic asthma induces T-cell exhaustion and impairs virus clearance in mice. Respir. Res. 24, 160. https:\/\/doi.org\/10.1186\/s12931-023-02448-9 (2023).","journal-title":"Respir. Res."},{"key":"76736_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jim.2015.06.011","volume":"425","author":"F Liang","year":"2015","unstructured":"Liang, F. et al. Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques. J. Immunol. Methods. 425, 69\u201378 (2015).","journal-title":"J. Immunol. Methods"},{"key":"76736_CR78","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4110\/in.2017.17.5.326","volume":"17","author":"EJ Ko","year":"2017","unstructured":"Ko, E. J., Lee, Y. T., Lee, Y., Kim, K. H. & Kang, S. M. Distinct effects of Monophosphoryl lipid A, oligodeoxynucleotide CpG, and Combination adjuvants on modulating Innate and Adaptive Immune responses to Influenza Vaccination. Immune Netw. 17, 326. https:\/\/doi.org\/10.4110\/in.2017.17.5.326 (2017).","journal-title":"Immune Netw."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76736-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T12:05:11Z","timestamp":1729857911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76736-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76736"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76736-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"6 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25353"}}